China Aims To Synchronize With Global Drug Approvals By 2025

 
• By Dexter Jie Yan
  
China five year plan
China prioritizing synchronized evaluation, review and approval of innovative drugs and medical devices developed elsewhere • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from China

More from Asia